Theriva Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TOVX and other ETFs, options, and stocks.About TOVX
Theriva Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-020 and SYN-004.
CEOSteven A. Shallcross
CEOSteven A. Shallcross
Employees22
Employees22
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2001
Founded2001
Employees22
Employees22
TOVX Key Statistics
Market cap7.70M
Market cap7.70M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume2.37M
Average volume2.37M
High today$0.2446
High today$0.2446
Low today$0.21
Low today$0.21
Open price$0.2135
Open price$0.2135
Volume2.39M
Volume2.39M
52 Week high$2.08
52 Week high$2.08
52 Week low$0.201
52 Week low$0.201
Stock Snapshot
As of today, Theriva Biologics(TOVX) shares are valued at $0.24. The company's market cap stands at 7.7M, with a P/E ratio of -0.04.
During the trading session on 2025-11-25, Theriva Biologics(TOVX) shares reached a daily high of $0.24 and a low of $0.21. At a current price of $0.24, the stock is +12.0% higher than the low and still -3.9% under the high.
Trading volume for Theriva Biologics(TOVX) stock has reached 2.39M, versus its average volume of 2.37M.
The stock's 52-week range extends from a low of $0.20 to a high of $2.08.
The stock's 52-week range extends from a low of $0.20 to a high of $2.08.
People also own
Based on the portfolios of people who own TOVX. This list is generated using Robinhood data, and it’s not a recommendation.